CardioComm Solutions, Inc.EKG.V

Health Care · Health Care Equipment & Services · TSX-V · Canada · cardiocommsolutions.com

CardioComm Solutions, Inc. develops software, hardware, and core laboratory reading services related to electrocardiogram (ECG) and ambulatory arrhythmia monitoring systems for medical and consumer markets worldwide. Its products include the GEMS remote patient monitoring platform and HeartCheck mobile ECG devices, with regulatory clearances from Health Canada, the FDA, and European CE Mark. The company is headquartered in Toronto, Canada.

Key ratios

FCF / Sales

-116.3%TTM

2024 -22.0%2023 -6.4%2022 4.4%

Net margin

-110.1%TTM

2024 -36.9%2023 -11.1%2022 -0.3%

ROA

-91.0%TTM

2024 -51.1%2023 -28.2%2022 -3.7%

Recent news

CardioComm Solutions and Predictiv AI Enter into Strategic AI Collaboration 2026-06-08 · Newsfile Corp CardioComm Announces Adoption of Quarterly Reporting Exemption Under Coordinated Blanket Order 51-933 2026-05-08 · Newsfile Corp CardioComm Solutions Announces Royalty-Based Financing Deal 2025-10-01 · Newsfile Corp

Track EKG.V in your journal

Save it to a watchlist, run a reverse DCF, and keep your notes on the company in one place. Free to start.

Create a free account

Figures are sourced from third parties and shown for research only. They may be delayed or incomplete, and nothing on this page is investment advice or a recommendation to buy or sell. Read the full disclaimer